drug

molecular-architecture-of-the-tas2r43-receptor-reveals-the-mechanisms-behind-coffee-bitterness-and-new-pathways-for-drug-development

Molecular Architecture of the TAS2R43 Receptor Reveals the Mechanisms Behind Coffee Bitterness and New Pathways for Drug Development

Dzikria Novita May 11, 2026

The sensory experience of a morning cup of coffee is often a study in...

new-drug-cuts-seizures-by-up-to-91-in-children-with-rare-epilepsy-1

New drug cuts seizures by up to 91% in children with rare epilepsy

Nila Kartika Wati May 9, 2026

An international clinical trial, spearheaded by researchers at UCL (University College London) and Great...

new-drug-cuts-seizures-by-up-to-91-in-children-with-rare-epilepsy

New drug cuts seizures by up to 91% in children with rare epilepsy

Nila Kartika Wati May 2, 2026

The groundbreaking study, published in The New England Journal of Medicine, details how children...

new-drug-cuts-seizures-by-up-to-91-in-children-with-rare-epilepsy-1

New drug cuts seizures by up to 91% in children with rare epilepsy

Nila Kartika Wati April 17, 2026

An experimental therapy, zorevunersen, for children suffering from Dravet syndrome, a severe and notoriously...

new-drug-cuts-seizures-by-up-to-91-in-children-with-rare-epilepsy

New drug cuts seizures by up to 91% in children with rare epilepsy

Nila Kartika Wati April 9, 2026

A Breakthrough in Dravet Syndrome Treatment The groundbreaking study, published in the prestigious New...